AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 39 filers reported holding AIM IMMUNOTECH INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $67,340 | -28.2% | 148,000 | +5.7% | 0.00% | 0.0% |
| Q2 2023 | $93,800 | +51.5% | 140,000 | -2.8% | 0.00% | 0.0% |
| Q1 2023 | $61,920 | +29.8% | 144,000 | -5.9% | 0.00% | 0.0% |
| Q4 2022 | $47,721 | -46.4% | 153,000 | -50.0% | 0.00% | 0.0% |
| Q3 2022 | $89,089 | -25.1% | 306,004 | +100.0% | 0.00% | -50.0% |
| Q2 2022 | $119,000 | -26.5% | 153,002 | +0.0% | 0.00% | 0.0% |
| Q1 2022 | $162,000 | +8.7% | 153,000 | -5.6% | 0.00% | +100.0% |
| Q4 2021 | $149,000 | -50.3% | 162,000 | +9.1% | 0.00% | -66.7% |
| Q3 2021 | $300,000 | +29.3% | 148,479 | +37.5% | 0.00% | +50.0% |
| Q2 2021 | $232,000 | -5.3% | 108,000 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $245,000 | +129.0% | 108,000 | +80.0% | 0.00% | +200.0% |
| Q4 2020 | $107,000 | +24.4% | 60,000 | +50.0% | 0.00% | -50.0% |
| Q3 2020 | $86,000 | – | 40,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| XTX MARKETS LLC | 11,019 | $20,000 | 0.04% |
| Virtu Financial LLC | 103,807 | $186,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 10,000 | $18,000 | 0.01% |
| SeaCrest Wealth Management, LLC | 48,873 | $87,000 | 0.01% |
| Arkadios Wealth Advisors | 20,000 | $35,000 | 0.01% |
| Traynor Capital Management, Inc. | 14,777 | $26,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 17,047 | $31,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 111,000 | $199,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 20,200 | $36,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 12,513 | $22,000 | 0.00% |